A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer.
Clin Colorectal Cancer
; 18(4): e349-e360, 2019 12.
Article
in En
| MEDLINE
| ID: mdl-31351862
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Radiosurgery
/
Cyclophosphamide
/
Programmed Cell Death 1 Receptor
/
Antineoplastic Agents, Immunological
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Colorectal Cancer
Journal subject:
GASTROENTEROLOGIA
/
NEOPLASIAS
Year:
2019
Document type:
Article
Country of publication:
United States